For prostate cancer in particular, previous studies linking inflammation to neoplasia were potentially subject to detection bias, as prostatitis is associated with an elevated prostate-specific antigen (PSA) level and may therefore be more likely to be screened for prostate cancer (70). This evidence concerns the gene KLK3 and medical procedure.